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In zoo practice, for physical examination or medical procedure in captive tigers, chemical 
immobilization is needed and ketamine (KET) in association with sedatives is an option 
frequently used (Clark-Price et al., 2015). Aims of the study is the assessment of the 
pharmacokinetics of KET and its main metabolite, norketamine (NORKET), after its 
intramuscular administration in combination with dexmedetomidine in tigers. 
Nineteen adult captive tigers, from different zoos, were scheduled for periodic physical 
examination or diagnostic procedures at the Milan University facilities. All animals were 
administered with a combination of KET at 2 mg/kg and dexmedetomidine at 10 µg/kg, given 
intramuscularly through blowpipe darts. If necessary, tigers where re-administered with variable 
doses of KET and dexmedetomidine or other drugs. When animals were sufficiently sedated, 
blood samples were collected every 5-10 min for the time tigers were safely approachable. Nine 
animals were assigned to standard protocol group (KET 2 mg/kg and dexmedetomidine 10 
µg/kg) and ten animals to non-standard protocol group (tigers administered with different 
doses of KET, 2 – 2.5 mg/kg, and dexmedetomidine 10 – 30 µg/kg or with any other necessary 
drug, such as titrate-to-effect propofol and isoflurane, respectively for anaesthesia induction 
and maintenance). Ketamine and NORKET were extracted from plasma according to a validated 
HPLC-UV method (Zonca et al., 2012). For pharmacokinetic assessment, KET and NORKET 
concentrations were analysed with a noncompartmental approach (Phoenix® 7.0, Pharsight). 
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Differences in the pharmacokinetic parameters between groups were statistically analysed 
(SPSS 25.0, SPSS Inc.). Results are reported in Table 1. 
This is the first study that evaluates the pharmacokinetics of KET and NORKET in tigers. Due to 
the harmful attitude of these animals, samples collection was limited to the period of sedation, a 
short time for a complete pharmacokinetic evaluation. Nevertheless, we observed a favorable 
kinetic profile of KET and NORKET and, from a clinical point of view, all animals showed a good 
recovery, no adverse effects and a good level of sedation. 
 
 
   
Standard Protocol              
(mean ± s.d.) 
Non-Standard 
protocol             
(mean ± s.d.) 
   
  
Ketamine HL_Lambda_z min 77.62 ± 54.50 76.14 ± 67.32 
 Tmax min 27.78 ± 7.90 49.70 ± 29.64 
 Cmax ug/mL 0.63 ± 0.17 0.67 ± 0.19 
 AUClast min*ug/mL 23.84 ±6.40* 35.97 ± 12.84* 
 AUMClast min*min*ug/mL 802.24 ± 331.03* 2054.97 ± 1018.88* 
 MRTlast min 32.88 ± 5.71* 54.38 ± 19.71* 
     
Norketamine Tmax min 51.89 ± 8.95* 77.10 ± 24.41* 
 Cmax ug/mL 0.24 ± 0.07 0.23 ± 0.09 
 AUClast min*ug/mL 7.30 ± 3.98 11.07 ± 5.46 
 AUMClast min*min*ug/mL 291.94 ± 227.01* 701.87 ± 424.80* 
 MRTlast min 36.95 ± 7.32* 58.65 ± 19.58* 
HL_Lambda_z = Elimination Half-Life; Tmax = Time to Maximum concentration; Cmax = Maximum 
Concentration; AUClast = Area Under the Curve to the last concentration; AUMClast = Area under 
the first Moment Curve to the last concentration ;MRTlast = Mean Residence Time to the last 
concentration. 
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Table 1: Pharmacokinetic parameters of ketamine and norketamine in nineteen adult captive tigers after 
intramuscular administration of 2 mg/kg of ketamine, with or without variation from the standard protocol, in 
combination with dexmedetomidine (with * are indicated results with p < 0.05). 
